Shirin Akter

Mrs. Shirin Akter

orcid
PhD student (Chemistry)

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 June 2025 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
ASArpit Sharma
Arpit Sharma
WJWjdan Jogadi
Wjdan Jogadi
MKMan Kshetri
Man Kshetri
SASuha Alqarni
Suha Alqarni
AAAl Amin
Al Amin
YZyaorong zheng
yaorong zheng

16 September 2025 in Angewandte Chemie International Edition
Verified
Journal Article
Open access
ASArpit Sharma
Arpit Sharma
MKMan Kshetri
Man Kshetri
DKDeepak Karna
Deepak Karna
AAAl Amin
Al Amin
Shirin AkterShirin Akter
Shirin Akter
YZyaorong zheng
yaorong zheng
Precise molecular activation with both analyte specificity and spatiotemporal control remains a major challenge in responsive diagnostics, targeted therapies, and the study of complex biological systems. Traditional photo‐uncaging strategies offer excellent temporal resolution but suffer from limited tissue penetration and poor biological specificity, while analyte‐responsive platforms provide molecular selectivity without external control. Here, we introduce sequence‐responsive diagnostic uncaging—a unique approach that integrates nucleic acid recognition with near‐infrared (NIR)‐triggered molecular activation within a metal‐nucleic acid scaffold. This platform is built upon a first‐of‐its‐kind Pt(IV)‐DNA molecular scaffold, modularly assembled via click chemistry, and integrates a Pt(IV)‐caged reporter, a nucleic acid recognition domain, and an NIR antenna (e.g., IR800). Notably, DNA‐mediated electron transfer (DNA‐MET) provides a long‐range ET pathway to direct photoreduction of the Pt(IV) centers, enabling “responsive uncaging” that occurs only upon hybridization with a fully complementary DNA or miRNA strand. Upon NIR irradiation, the duplexed nucleic acid system facilitates electron transfer from the excited antenna to Pt(IV), triggering the release of fluorescent reporters. Using two Pt(IV)‐caged fluorophores (MCA and BDP), we demonstrate efficient uncaging and high sequence specificity in both solution and live cells. This platform offers a powerful and versatile photochemical tool that seamlessly bridges diagnostics and molecular activation, with broad implications for precision medicine, targeted drug delivery, and next‐generation biosensing technologies.

29 March 2025 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
ASArpit Sharma
Arpit Sharma
MAMd Al Amin
Md Al Amin
MKMan Kshetri
Man Kshetri
SASuha Alqarni
Suha Alqarni
WJWjdan Jogadi
Wjdan Jogadi
YZyaorong zheng
yaorong zheng
Background/Objectives: The utilization of amphiphilic Pt(IV) complexes as prodrugs offers a promising strategy to revolutionize Pt-based cancer therapy by enhancing drug delivery and activation. While PEGylation is widely used to optimize drug properties, its impact on the biological behavior of amphiphilic Pt(IV) complexes remains unclear. This study systematically investigates how the PEGylation of varying molecular weights influences their cytotoxicity, cellular uptake, and activation. Methods: Pt(IV) complexes were synthesized with PEG chains of different molecular weights using HATU-catalyzed amide bond formation and copper-free click chemistry. Their biological properties were assessed through cell-based analyses, focusing on cytotoxicity, cellular uptake, and activation by biological reductants. Results: Small PEG modifications retained the potent cytotoxicity of amphiphilic Pt(IV) prodrugs, whereas large PEG chains significantly reduced efficacy. The decrease in potency was linked to impaired cellular uptake and mitochondrial accumulation. Additionally, large PEG modifications slowed the reduction and activation of Pt(IV) prodrugs by biological reductants, further limiting their anticancer activities. Conclusions: These findings underscore the critical role of PEGylation in metallodrug design and provide key insights into optimizing PEGylation strategies for enhancing platinum–based cancer therapies.

16 September 2025 in Angewandte Chemie
Verified
Journal Article
Open access
ASArpit Sharma
Arpit Sharma
MKMan Kshetri
Man Kshetri
DKDeepak Karna
Deepak Karna
AAAl Amin
Al Amin
Shirin AkterShirin Akter
Shirin Akter
YZyaorong zheng
yaorong zheng
Precise molecular activation with both analyte specificity and spatiotemporal control remains a major challenge in responsive diagnostics, targeted therapies, and the study of complex biological systems. Traditional photo‐uncaging strategies offer excellent temporal resolution but suffer from limited tissue penetration and poor biological specificity, while analyte‐responsive platforms provide molecular selectivity without external control. Here, we introduce sequence‐responsive diagnostic uncaging—a unique approach that integrates nucleic acid recognition with near‐infrared (NIR)‐triggered molecular activation within a metal‐nucleic acid scaffold. This platform is built upon a first‐of‐its‐kind Pt(IV)‐DNA molecular scaffold, modularly assembled via click chemistry, and integrates a Pt(IV)‐caged reporter, a nucleic acid recognition domain, and an NIR antenna (e.g., IR800). Notably, DNA‐mediated electron transfer (DNA‐MET) provides a long‐range ET pathway to direct photoreduction of the Pt(IV) centers, enabling “responsive uncaging” that occurs only upon hybridization with a fully complementary DNA or miRNA strand. Upon NIR irradiation, the duplexed nucleic acid system facilitates electron transfer from the excited antenna to Pt(IV), triggering the release of fluorescent reporters. Using two Pt(IV)‐caged fluorophores (MCA and BDP), we demonstrate efficient uncaging and high sequence specificity in both solution and live cells. This platform offers a powerful and versatile photochemical tool that seamlessly bridges diagnostics and molecular activation, with broad implications for precision medicine, targeted drug delivery, and next‐generation biosensing technologies.